NU Online News Service, Aug. 10, 1:56 p.m. – The Centre Group, Hamilton, Bermuda, an arm of Zurich Financial Services Group, says it has used an unusual investment strategy to help Royalty Pharma A.G. Schaffhausen, Switzerland, a pharmaceutical company, get $60 million in loans.
NOT FOR REPRINT
Zurich Unit Turns Prescription Drug Royalties Into Collateral
By
Staff Writer
August 10, 2001 at 08:00 PM
Share & Print
Centre helped Royalty Pharma get the financing by turning the expected royalty streams from a portfolio of nine prescription drugs that are already on the market, and another drug that is still in development, into collateral.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
